Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Johnson & Johnson ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 USA

www.jnj.com Employees: 138,100 P: 732-524-0400

Sector:

Medical

Description:

Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.

Key Statistics

Overview:

Market Capitalization, $K 526,816,448
Enterprise Value, $K 533,362,432
Shares Outstanding, K 2,409,295
Float, K 2,405,440
% Float 99.84%
Short Interest, K 20,427
Short Float 0.85%
Days to Cover 2.71
Short Volume Ratio 0.39
% of Insider Shareholders 0.16%
% of Institutional Shareholders 69.55%

Financials:

Annual Sales, $ 88,821 M
Annual Net Income, $ 14,066 M
Last Quarter Sales, $ 23,993 M
Last Quarter Net Income, $ 5,152 M
EBIT, $ 29,302 M
EBITDA, $ 36,641 M

Growth:

1-Year Return 48.41%
3-Year Return 29.58%
5-Year Return 33.70%
5-Year Revenue Growth 8.24%
5-Year Earnings Growth 14.98%
5-Year Dividend Growth 30.93%

Per-Share Information:

Most Recent Earnings 2.80 on 10/14/25
Next Earnings Date 01/21/26 [BMO]
Earnings Per Share ttm 10.38
EPS Growth vs. Prev Qtr 1.08%
EPS Growth vs. Prev Year 15.70%
Annual Dividend & Yield (Paid) 5.14 (2.35%)
Annual Dividend & Yield (Fwd) 5.20 (2.38%)
Most Recent Dividend 1.300 on 11/25/25
Next Ex-Dividends Date 02/24/26
Dividend Payable Date 03/10/26
Dividend Payout Ratio 48.63%
Most Recent Split 2-1 on 06/13/01

JNJ Ratios

Ratio
Price/Earnings ttm 21.15
Price/Earnings forward 19.08
Price/Earnings to Growth 2.25
Return-on-Equity % 32.73%
Return-on-Assets % 13.24%
Profit Margin % 15.84%
Debt/Equity 0.50
Price/Sales 5.76
Price/Cash Flow 16.67
Price/Book 6.65
Book Value/Share 32.90
Interest Coverage 23.10
60-Month Beta 0.34

JNJ Dividends

Date Value
11/25/25 $1.3000
08/26/25 $1.3000
05/27/25 $1.3000
02/18/25 $1.2400
11/26/24 $1.2400
08/27/24 $1.2400
05/20/24 $1.2400
02/16/24 $1.1900
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar